new-pharma300x111.jpg
While Over Three-Quarters of Americans Are Willing to Take at Least One of the Authorized COVID-19 Vaccines, Nearly a Quarter Are Still Hesitant as the U.S. Changes Course on Mitigation Strategy
June 03, 2021 13:21 ET | Informa Business Intelligence
NEW YORK, June 03, 2021 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, released its “Q2 2021 Clinical Trials and the COVID-19...
PDS Biotech Logo.png
PDS Biotechnology Expands VERSATILE-002 study of PDS0101 and KEYTRUDA® in Advanced Head and Neck Cancer to Include Patients Who Have Failed Prior Treatment with Checkpoint Inhibitors
June 03, 2021 08:53 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., June 03, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
Axiom_20Years_Updated logo.jpg
Axiom Presents "Unified Platforms: Key Modules and Data Considerations for Study Success" at eClinical & Clinical Data Management Innovation Conference
June 02, 2021 09:36 ET | Axiom Real-Time Metrics Inc
TORONTO, June 02, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will...
NOVARTIS logo.jpg
Novartis presents positive Phase III results from JUNIPERA study supporting Cosentyx® as a potential treatment in a JIA population at EULAR 2021
June 02, 2021 01:15 ET | Novartis Pharma AG
Phase III JUNIPERA study met its primary endpoint, with Cosentyx® (secukinumab) showing significantly longer time to flare (longer time to worsening of symptoms1) vs. placebo (P<.001) in pediatric...
RYAH logo.jpg
RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial
June 01, 2021 08:00 ET | Potbotics, Inc. o/a RYAH
TORONTO, June 01, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – RYAH Group, Inc. (CSE:RYAH) (“RYAH” or the “Company”) is pleased to announce that it has completed the first shipment of the RYAH Smart...
22157.jpg
Chronic Pain Clinical Trial Pipeline Report 2021: Global Clinical Trial Stages, Drug Mechanism Classes, Companies, Short-term Launch Highlights
May 31, 2021 07:33 ET | Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "Global Chronic Pain Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering. The latest report Chronic...
22157.jpg
Post-Operative Pain Clinical Trial Pipeline Report 2021: Global Clinical Trial Stages, Drug Mechanism Classes, Companies, Short-term Launch Highlights
May 31, 2021 07:28 ET | Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "Global Post-Operative Pain Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering. Post-Operative Pain...
22157.jpg
Global Asthma Clinical Trial Pipeline Report 2021: Clinical Trial Stages, Drug Mechanism Classes, Companies, Short-term Launch Highlights
May 28, 2021 08:28 ET | Research and Markets
Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Global Asthma Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering. sthma Pipeline Highlights - 2021,...
22157.jpg
Global Bladder Cancer Clinical Trial Pipeline Report 2021: Clinical Trial Stages, Drug Mechanism Classes, Companies, Short-term Launch Highlights
May 28, 2021 08:23 ET | Research and Markets
Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Global Bladder Cancer Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering. The latest report Bladder...
22157.jpg
Global Acute Pain Clinical Trial Pipeline Report 2021: Clinical Trial Stages, Drug Mechanism Classes, Companies, Short-term Launch Highlights
May 28, 2021 08:18 ET | Research and Markets
Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Global Acute Pain Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering. Acute Pain Pipeline Highlights...